Cumberland Pharmaceuticals Inc. (CPIX)

Every figure this model derived for CPIX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 62,070 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 3,862,402 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 33,641,145 AssetsCurrent 2026-06-30
current liabilities 35,193,138 LiabilitiesCurrent 2026-06-30
equity 17,438,013 StockholdersEquity 2026-06-30
interest expense 309,204 InterestExpense 2026-06-30
ocf 745,969 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 39,903,571 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 438,130 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up CPIX on one particular measure came for.

RatioValue
cash operating margin-12.65
current ratio0.96
current ratio reported0.96
deferred revenue growth-87.93
dilution pct5.65
fcf margin1.71
growth cv2.24
interest cover-31.13
operating margin-24.12
owner earnings margin0.62
revenue growth-5.15
revenue growth per share-10.23
roic-56.02
rule of 40-29.28
sbc pct revenue1.1

What to be careful about

What this model itself distrusts about CPIX's figures. Written by the derivation as it ran, not added afterwards.